Micronutrients & recovery
Supplementation with 500 mg/day of resveratrol for 12 weeks significantly reduces serum alanine aminotransferase (ALT) and hepatic steatosis in patients with non-alcoholic fatty liver disease (NAFLD) compared to placebo.
If you have NAFLD, taking 500 mg of resveratrol daily for 12 weeks may help lower liver enzymes (ALT) and reduce liver fat, but it will not fix your cholesterol, blood pressure, or insulin resistance. Do not rely on it as a substitute for a healthy diet and regular exercise.
resveratrol supplementation reduced alanine aminotransferase (ALT) and hepatic steatosis significantly more than placebo (P < 0·05).
Why this rating
Randomized, double-blind, placebo-controlled clinical trial with adequate blinding and high adherence, though sample size is modest (n=50).
Source
The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study
Forouzan Faghihzadeh et al. · British Journal Of Nutrition · 2015
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →